Empowering clinicians with AI medical technologies that solve real challenges.
About Us
Keya Medical is redefining how clinicians evaluate and manage coronary artery disease through advanced artificial intelligence and data-driven imaging analysis.
Keya Medical is an international medical technology company specializing in deep learning-based solutions for cardiovascular diagnosis. Its flagship product, DEEPVESSEL FFR, is an FDA-cleared, CE-marked, NMPA-approved, and certified by HSA of Singapore CT-FFR analysis that provides non-invasive coronary artery assessment using CCTA.
To learn more about Keya Medical, follow us on LinkedIn, Twitter, and Facebook.
Our Team
Letter from Mary-Pierre Waiss, President, North America
Welcome to Keya Medical.
Here, we believe that behind every scan, every diagnosis, and every innovation is a person — someone’s parent, child, or friend. That’s why our team is dedicated to combining cutting-edge deep learning technology with a deep sense of care.
Our presence in the United States continues to grow, and we are building a talented team committed to supporting clinicians, advancing research, and strengthening our partnerships across the cardiovascular community. Our advanced CCTA analysis tools are designed to help clinicians work faster and with greater accuracy.
Together, we’re shaping a future where heart health is stronger and patients’ outcomes are better.
Mary-Pierre Waiss – President, Keya Medical
Mary-Pierre Waiss
President, North America
Mary Waiss is a seasoned leader in biotechnology and healthcare technology with deep experience advancing innovation in patient care. She has held leadership and board positions at leading organizations including Keya Medical, Evergreen Bioscience Innovation Cluster, Precision Image Analysis, VentriPoint Diagnostics, and Boston Children’s Hospital, part of the Harvard Medical School system. She is dedicated to driving progress in cardiovascular imaging and improving care for patients with cardiovascular disease.
Chad Thomas
Sales Director, US South Region
Matt Dichard
Sales Director, US Northeast Region
Mitch McCahey
Sales Director, US Northwest Region
Mitch McCahey is a veteran commercial sales and leadership executive with more than 30 years in cardiovascular medical devices at Boston Scientific, JNJ, Terumo, Medtronic, and Abbott. From 2019–2023, he helped lead HeartFlow’s CT-FFR adoption in the Pacific NW, establishing programs at Kaiser, Providence, Sutter, and the UC system, with his territory among the first to reach profitability. Mitch brings deep expertise in invasive and non-invasive FFR and strong knowledge of the U.S. cardiology and radiology markets.
Our Story
Reseller Partners
Intended for the U.S. market only. Not for EU promotional use.